Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis

The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab with chemotherapy as the first-line treatment in Chinese patients with metastatic colorectal cancer (mCRC). Clinical data were collected from a single-center registry study wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Long, Wang, Feng, Li, Zhe-zhen, Ren, Chao, Zhang, Dong-sheng, Zhao, Qi, Lu, Yun-xin, Wang, De-shen, Ju, Huai-qiang, Qiu, Miao-zhen, Wang, Zhi-qiang, Wang, Feng-hua, Xu, Rui-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181797/
https://www.ncbi.nlm.nih.gov/pubmed/28002313
http://dx.doi.org/10.1097/MD.0000000000004531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181797/
https://www.ncbi.nlm.nih.gov/pubmed/28002313
http://dx.doi.org/10.1097/MD.0000000000004531

Ejemplares similares